Streetbeat News

COPHF

Creso Pharma Limited

http://cresopharma.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.00

Mkt cap

132M

Volume

High

0.12

P/E Ratio

-0.02

52-wk high

9.47

Low

0.00

Div yield

N/A

52-wk low

0.00

The Energia Foundation is hosting a psychedelics education event in Dubai, while new research finds a key receptor for treating depression with psychedelics. Creso Pharma (OTC:COPHF) signs an LOI for importing Swiss MDMA and psilocybin therapeutics to Australia. AdvisorShares Psychedelics ETF (NYSE:PSIL) shows a consistent upward trend.

Portfolio Pulse from Lara Goldstein

June 13, 2023 | 2:31 pm

Creso Pharma (OTC:COPHF) signed a Letter of Intent (LOI) with Swiss pharmacy Apotheke Dr. Hysek AG for an exclusive partnership to import and distribute licensed MDMA and psilocybin products into Australia. The partnership follows Australia's new legal framework for psychedelic-assisted therapies, and Creso Pharma will provide import infrastructure through its subsidiary Health House International (HHI).

Portfolio Pulse from Lara Goldstein

June 09, 2023 | 6:27 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.